Webcasts

Developing Liquid Formulations for the Oral Dosing of Lipophilic Drugs

Tuesday, October 4, 2022 at 11am CDT |12pm EDT | 9am PDT Is developing formulations of highly lipophilic compounds worth the effort? With today’s excipients and technologies, the answer is a definite yes. This presentation will showcase the issues presented by lipophilic compounds and ways to address them.

Advancing OSD: Continuous Production Considerations and Dose-Level Authentication

Thursday, September 28, 2022 at 11am ET | 10am CT | 8am PT Learn the key benefits of continuous OSD production as well as the importance of authenticating OSD products at the dose-level with experts from Syntegon and Colorcon in this episode of the PharmTech Drug Digest Video Series.

Dispersome® – Understanding formulation principles and manufacturing behind this new Bioavailability Enhancing Technology

Thursday, September 8, 2022 at 11am EDT; 4pm GMT; 5pm CEST This webinar will highlight the new solubility enhancing Dispersome® technology, which is based on the amorphous stabilization of a given drug using the protein beta-lactoglobulin (BLG) as novel pharmaceutical excipient. Several relevant case studies are presented to showcase the potential of this new technology. Subsequently, the webinar provides a roadmap on how these formulations can be manufactured on a commercial scale. The webinar will also cover the manufacturing of the formulations.

Sterilization’s Horizon: Improving Automation, Single-Use Technologies, and Annex 1

Thu, Aug 25, 2022 11:00 AM EDT Pharmaceutical Technology editors interview aseptic and sterilization experts from Watson-Marlow Fluid Technology Solutions and Cherwell—diving into sterilization, aseptic processing, and the revised EU GMP Annex 1 guidance.

Allowing You to do More with Less: The TRS100 Transmission Raman System

Thursday, ​​​​July 21st, 2022 at 11am EDT|8am PDT|4pm BST|5pm CEST Learn about the use of molecular spectroscopy techniques – transmission Raman spectroscopy (TRS) and laser direct infrared (LDIR) – for solid-state analysis in pharmaceutical formulation development.